IBDEI0T2 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13627,1,4,0)
 ;;=4^Z82.1
 ;;^UTILITY(U,$J,358.3,13627,2)
 ;;=^5063365
 ;;^UTILITY(U,$J,358.3,13628,0)
 ;;=Z82.2^^53^594^27
 ;;^UTILITY(U,$J,358.3,13628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13628,1,3,0)
 ;;=3^Family Hx of Deafness/Hearing Loss
 ;;^UTILITY(U,$J,358.3,13628,1,4,0)
 ;;=4^Z82.2
 ;;^UTILITY(U,$J,358.3,13628,2)
 ;;=^5063366
 ;;^UTILITY(U,$J,358.3,13629,0)
 ;;=Z84.0^^53^594^48
 ;;^UTILITY(U,$J,358.3,13629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13629,1,3,0)
 ;;=3^Family Hx of Skin Diseases
 ;;^UTILITY(U,$J,358.3,13629,1,4,0)
 ;;=4^Z84.0
 ;;^UTILITY(U,$J,358.3,13629,2)
 ;;=^5063388
 ;;^UTILITY(U,$J,358.3,13630,0)
 ;;=Z82.79^^53^594^26
 ;;^UTILITY(U,$J,358.3,13630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13630,1,3,0)
 ;;=3^Family Hx of Congen Malform,Deformations & Chromsoml Abnlt
 ;;^UTILITY(U,$J,358.3,13630,1,4,0)
 ;;=4^Z82.79
 ;;^UTILITY(U,$J,358.3,13630,2)
 ;;=^5063374
 ;;^UTILITY(U,$J,358.3,13631,0)
 ;;=Z84.89^^53^594^46
 ;;^UTILITY(U,$J,358.3,13631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13631,1,3,0)
 ;;=3^Family Hx of Other Spec Conditions
 ;;^UTILITY(U,$J,358.3,13631,1,4,0)
 ;;=4^Z84.89
 ;;^UTILITY(U,$J,358.3,13631,2)
 ;;=^5063393
 ;;^UTILITY(U,$J,358.3,13632,0)
 ;;=Z81.1^^53^594^20
 ;;^UTILITY(U,$J,358.3,13632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13632,1,3,0)
 ;;=3^Family Hx of Alcohol Abuse/Dependence
 ;;^UTILITY(U,$J,358.3,13632,1,4,0)
 ;;=4^Z81.1
 ;;^UTILITY(U,$J,358.3,13632,2)
 ;;=^5063359
 ;;^UTILITY(U,$J,358.3,13633,0)
 ;;=Z82.62^^53^594^45
 ;;^UTILITY(U,$J,358.3,13633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13633,1,3,0)
 ;;=3^Family Hx of Osteoporosis
 ;;^UTILITY(U,$J,358.3,13633,1,4,0)
 ;;=4^Z82.62
 ;;^UTILITY(U,$J,358.3,13633,2)
 ;;=^5063372
 ;;^UTILITY(U,$J,358.3,13634,0)
 ;;=Z83.71^^53^594^25
 ;;^UTILITY(U,$J,358.3,13634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13634,1,3,0)
 ;;=3^Family Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,13634,1,4,0)
 ;;=4^Z83.71
 ;;^UTILITY(U,$J,358.3,13634,2)
 ;;=^5063386
 ;;^UTILITY(U,$J,358.3,13635,0)
 ;;=Z84.81^^53^594^29
 ;;^UTILITY(U,$J,358.3,13635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13635,1,3,0)
 ;;=3^Family Hx of Genetic Disease
 ;;^UTILITY(U,$J,358.3,13635,1,4,0)
 ;;=4^Z84.81
 ;;^UTILITY(U,$J,358.3,13635,2)
 ;;=^5063392
 ;;^UTILITY(U,$J,358.3,13636,0)
 ;;=Z86.010^^53^594^76
 ;;^UTILITY(U,$J,358.3,13636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13636,1,3,0)
 ;;=3^Personal Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,13636,1,4,0)
 ;;=4^Z86.010
 ;;^UTILITY(U,$J,358.3,13636,2)
 ;;=^5063456
 ;;^UTILITY(U,$J,358.3,13637,0)
 ;;=Z86.14^^53^594^81
 ;;^UTILITY(U,$J,358.3,13637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13637,1,3,0)
 ;;=3^Personal Hx of MRSA Infection
 ;;^UTILITY(U,$J,358.3,13637,1,4,0)
 ;;=4^Z86.14
 ;;^UTILITY(U,$J,358.3,13637,2)
 ;;=^5063464
 ;;^UTILITY(U,$J,358.3,13638,0)
 ;;=Z86.31^^53^594^77
 ;;^UTILITY(U,$J,358.3,13638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13638,1,3,0)
 ;;=3^Personal Hx of Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,13638,1,4,0)
 ;;=4^Z86.31
 ;;^UTILITY(U,$J,358.3,13638,2)
 ;;=^5063467
 ;;^UTILITY(U,$J,358.3,13639,0)
 ;;=Z86.711^^53^594^107
 ;;^UTILITY(U,$J,358.3,13639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13639,1,3,0)
 ;;=3^Personal Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,13639,1,4,0)
 ;;=4^Z86.711
 ;;^UTILITY(U,$J,358.3,13639,2)
 ;;=^5063474
 ;;^UTILITY(U,$J,358.3,13640,0)
 ;;=Z86.72^^53^594^113
 ;;^UTILITY(U,$J,358.3,13640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13640,1,3,0)
 ;;=3^Personal Hx of Thrombophlebitis
